On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.
"It's amazing how many companies there are and how many opportunities for a kind of a match between a human that needs some help...
"Artificial Intelligence is a tool that really levels up and creates almost like an equity for everybody to participate and, when used effectively, to...
“Our studies are open for those that have exhausted standard of care, and we're showing improved responses, and the data is promising. So, I...